nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—Nafarelin—GNRHR—adrenal gland cancer	0.0841	0.962	CrCbGaD
Vapreotide—SSTR5—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0612	0.0671	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0565	0.0619	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0479	0.0525	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0445	0.0487	CbGpPWpGaD
Vapreotide—SSTR5—Peptide GPCRs—TSHR—adrenal gland cancer	0.0327	0.0358	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—TSHR—adrenal gland cancer	0.0302	0.0331	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—TSHR—adrenal gland cancer	0.0238	0.026	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0212	0.0232	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0193	0.0212	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.019	0.0208	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0178	0.0195	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0147	0.0161	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.014	0.0154	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0136	0.0149	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0127	0.0139	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0119	0.0131	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0116	0.0127	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0114	0.0124	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0107	0.0117	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0107	0.0117	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0103	0.0113	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00996	0.0109	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00952	0.0104	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00939	0.0103	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00881	0.00966	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00841	0.00921	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00831	0.00911	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00813	0.00891	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—TSHR—adrenal gland cancer	0.00785	0.00861	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00767	0.00841	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00755	0.00827	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00755	0.00827	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00749	0.00821	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00725	0.00794	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00697	0.00763	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00696	0.00763	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0064	0.00702	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—RB1—adrenal gland cancer	0.00622	0.00681	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00604	0.00662	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00602	0.0066	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00571	0.00625	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00556	0.00609	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00548	0.00601	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.00511	0.0056	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00508	0.00557	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00498	0.00546	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00469	0.00514	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00464	0.00509	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0046	0.00504	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00457	0.00501	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00452	0.00496	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00446	0.00489	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00444	0.00486	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00438	0.00479	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00422	0.00462	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00417	0.00457	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00415	0.00454	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00412	0.00451	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0041	0.00449	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00404	0.00443	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00403	0.00442	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0039	0.00427	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00383	0.00419	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00373	0.00408	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00372	0.00408	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00366	0.00401	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—EGFR—adrenal gland cancer	0.00362	0.00397	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00362	0.00396	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0036	0.00394	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS2—adrenal gland cancer	0.00337	0.0385	CrCbGaD
Vapreotide—TACR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00332	0.00364	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00329	0.0036	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00324	0.00355	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00322	0.00353	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—POMC—adrenal gland cancer	0.00308	0.00337	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TP53—adrenal gland cancer	0.00304	0.00333	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00301	0.0033	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00293	0.00322	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00293	0.00321	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00289	0.00317	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—POMC—adrenal gland cancer	0.00284	0.00311	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00283	0.0031	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0027	0.00296	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00267	0.00293	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00267	0.00293	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00258	0.00283	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00249	0.00273	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00247	0.0027	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00245	0.00269	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00244	0.00268	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00238	0.00261	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TSHR—adrenal gland cancer	0.00238	0.00261	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00234	0.00257	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00226	0.00248	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00225	0.00247	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00224	0.00246	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MEN1—adrenal gland cancer	0.00224	0.00245	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—POMC—adrenal gland cancer	0.00223	0.00245	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TSHR—adrenal gland cancer	0.0022	0.00241	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00216	0.00237	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0021	0.0023	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MEN1—adrenal gland cancer	0.00207	0.00226	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00196	0.00215	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00194	0.00213	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00188	0.00206	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00178	0.00195	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00178	0.00195	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00174	0.0019	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TSHR—adrenal gland cancer	0.00173	0.0019	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00171	0.00187	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.0017	0.00187	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00163	0.00178	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—POMC—adrenal gland cancer	0.0016	0.00176	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—POMC—adrenal gland cancer	0.00158	0.00173	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRKACA—adrenal gland cancer	0.00158	0.00173	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—POMC—adrenal gland cancer	0.00146	0.0016	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDC42—adrenal gland cancer	0.00145	0.00159	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF2—adrenal gland cancer	0.0014	0.00153	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GNAS—adrenal gland cancer	0.00138	0.00152	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1R—adrenal gland cancer	0.00135	0.00148	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDC42—adrenal gland cancer	0.00134	0.00147	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF2—adrenal gland cancer	0.00129	0.00141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GNAS—adrenal gland cancer	0.00128	0.0014	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00126	0.00138	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1R—adrenal gland cancer	0.00125	0.00137	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00124	0.00136	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TERT—adrenal gland cancer	0.00116	0.00127	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—POMC—adrenal gland cancer	0.00115	0.00126	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TERT—adrenal gland cancer	0.00107	0.00118	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDC42—adrenal gland cancer	0.00105	0.00115	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF2—adrenal gland cancer	0.00102	0.00111	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BAD—adrenal gland cancer	0.00101	0.00111	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNAS—adrenal gland cancer	0.00101	0.0011	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000981	0.00108	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BAD—adrenal gland cancer	0.000933	0.00102	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—POMC—adrenal gland cancer	0.000932	0.00102	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BRAF—adrenal gland cancer	0.000921	0.00101	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000893	0.000978	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—POMC—adrenal gland cancer	0.000861	0.000943	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BRAF—adrenal gland cancer	0.00085	0.000931	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TERT—adrenal gland cancer	0.000845	0.000926	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000824	0.000903	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BAD—adrenal gland cancer	0.000735	0.000805	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—POMC—adrenal gland cancer	0.000678	0.000742	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000669	0.000733	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000666	0.000729	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000648	0.000711	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000614	0.000673	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGFR—adrenal gland cancer	0.000527	0.000578	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGFR—adrenal gland cancer	0.000487	0.000533	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000484	0.00053	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—adrenal gland cancer	0.000443	0.000485	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—adrenal gland cancer	0.000409	0.000448	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000383	0.00042	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—adrenal gland cancer	0.000322	0.000352	CbGpPWpGaD
